SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001193125-17-250557
Filing Date
2017-08-08
Accepted
2017-08-08 06:09:03
Documents
8

Document Format Files

Seq Description Document Type Size
1 8-K d434413d8k.htm 425 50814
2 EX-2.1 d434413dex21.htm EX-2.1 669580
3 EX-10.1 d434413dex101.htm EX-10.1 48963
4 EX-10.2 d434413dex102.htm EX-10.2 44145
5 EX-10.3 d434413dex103.htm EX-10.3 19348
6 EX-99.1 d434413dex991.htm EX-99.1 26554
7 GRAPHIC g434413g0808081102232.jpg GRAPHIC 2608
8 GRAPHIC g434413g0808081102357.jpg GRAPHIC 4096
  Complete submission text file 0001193125-17-250557.txt   871155
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Filed by) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Subject) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-33958 | Film No.: 171013140
SIC: 2834 Pharmaceutical Preparations